Results 171 to 180 of about 4,233 (228)
Some of the next articles are maybe not open access.
Successful Treatment of Scleroderma with PUVA Therapy
Journal of Dermatology, 1996AbstractPUVA therapy was carried out on four patients with scleroderma; three of them had cutaneous manifestations of progressive systemic sclerosis and one other exhibited generalized morphea. PUVA therapy was given with daily doses of 0.25 J/cm2 or 0.4 J/cm2 for 3–8 weeks, resulting in total doses between 3.5 J/cm2 and 9.6 J/cm2.
Takuro Kanekura
exaly +3 more sources
OCULAR COMPLICATIONS OF PUVA THERAPY
Australasian Journal of Dermatology, 1993SummaryPUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of ...
J A, See, P, Weller
openaire +2 more sources
Journal of the American Academy of Dermatology, 2001
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire +2 more sources
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire +2 more sources
Melanonychia associated with PUVA therapy
Journal of the American Academy of Dermatology, 2003We describe a case of melanonychia induced by PUVA. This phenomenon likely is more common than the few reports in the literature indicate.
Leslie S, Ledbetter, Sylvia, Hsu
openaire +2 more sources
An Evaluation of PUVA-Therapy for Alopecia areata
Dermatologica, 200930 patients with alopecia areata were treated with 8-methoxypsoralen orally combined with whole body UVA exposure. 9 patients showed more than 60% regrowth of hair, 8 of them had recurrences of hair loss within a mean time of 7.7 months. No selecting criteria could be found prophesying good results of PUVA therapy.
van der Schaar, W. W. +1 more
openaire +3 more sources
Der Hautarzt, 1994
Systemic PUVA photochemotherapy is widely used for a variety of skin diseases. Administration of 8-methoxypsoralen in a dilute bathwater solution may be an effective alternative therapy with no systemic side-effects and requiring smaller amounts of UVA to induce the required phototoxic response.
Martina Kerscher +2 more
openaire +1 more source
Systemic PUVA photochemotherapy is widely used for a variety of skin diseases. Administration of 8-methoxypsoralen in a dilute bathwater solution may be an effective alternative therapy with no systemic side-effects and requiring smaller amounts of UVA to induce the required phototoxic response.
Martina Kerscher +2 more
openaire +1 more source
Dose Measurement in PUVA Therapy
Dermatologica, 2009The dose emitted by the fluorescent tubes used in PUVA therapy is not constant: it varies in function of time, age of the lamps, and several other factors. Exact knowledge of the dose given to the patient requires continuous measurement and integration of the UV-A output.
openaire +2 more sources
Photoprotection of the eye in PUVA therapy
British Journal of Dermatology, 1978Photochemotherapy with psoralens, now widely used in the therapy of psoriasis, vitiligo and mycosis fungoides, has been proposed to have the capacity, during long-term therapy, to induce ocular damage, e.g. cataract. This view is based on animal experiments (Cloud, Hakim & Griffin, 1960, 1961; Free-man & Troll, 1969) and as a consequence adequate ...
openaire +2 more sources
American family physician, 1991
PUVA is an acronym for psoralen plus ultraviolet-A radiation. This form of photochemical therapy is commonly used in the treatment of psoriasis and vitiligo, but it is also beneficial in other dermatologic diseases. An understanding of psoralen's mechanism of action and the unique properties of the various psoralen preparations is important in ensuring
T N, Helm +3 more
openaire +1 more source
PUVA is an acronym for psoralen plus ultraviolet-A radiation. This form of photochemical therapy is commonly used in the treatment of psoriasis and vitiligo, but it is also beneficial in other dermatologic diseases. An understanding of psoralen's mechanism of action and the unique properties of the various psoralen preparations is important in ensuring
T N, Helm +3 more
openaire +1 more source
Carcinogenic Risk of Bath PUVA in Comparison to Oral PUVA Therapy
Dermatology, 1999The potential carcinogenic risk of bath PUVA therapy was compared to that of systemic (oral) PUVA. An analysis of the epidemiological data on cancer risk following bath PUVA with trimethylpsoralen does not support the conclusion that bath PUVA per se is less carcinogenic than systemic PUVA with 8-methoxypsoralen (8-MOP).
Shephard SE, Panizzon RG
openaire +3 more sources